Literature DB >> 26010633

Copy number variations and cognitive phenotypes in unselected populations.

Katrin Männik1, Reedik Mägi2, Aurélien Macé3, Ben Cole4, Anna L Guyatt5, Hashem A Shihab6, Anne M Maillard7, Helene Alavere2, Anneli Kolk8, Anu Reigo2, Evelin Mihailov2, Liis Leitsalu9, Anne-Maud Ferreira10, Margit Nõukas9, Alexander Teumer11, Erika Salvi12, Daniele Cusi13, Matt McGue14, William G Iacono14, Tom R Gaunt6, Jacques S Beckmann15, Sébastien Jacquemont7, Zoltán Kutalik16, Nathan Pankratz4, Nicholas Timpson6, Andres Metspalu9, Alexandre Reymond17.   

Abstract

IMPORTANCE: The association of copy number variations (CNVs), differing numbers of copies of genetic sequence at locations in the genome, with phenotypes such as intellectual disability has been almost exclusively evaluated using clinically ascertained cohorts. The contribution of these genetic variants to cognitive phenotypes in the general population remains unclear.
OBJECTIVE: To investigate the clinical features conferred by CNVs associated with known syndromes in adult carriers without clinical preselection and to assess the genome-wide consequences of rare CNVs (frequency ≤0.05%; size ≥250 kilobase pairs [kb]) on carriers' educational attainment and intellectual disability prevalence in the general population. DESIGN, SETTING, AND PARTICIPANTS: The population biobank of Estonia contains 52,000 participants enrolled from 2002 through 2010. General practitioners examined participants and filled out a questionnaire of health- and lifestyle-related questions, as well as reported diagnoses. Copy number variant analysis was conducted on a random sample of 7877 individuals and genotype-phenotype associations with education and disease traits were evaluated. Our results were replicated on a high-functioning group of 993 Estonians and 3 geographically distinct populations in the United Kingdom, the United States, and Italy. MAIN OUTCOMES AND MEASURES: Phenotypes of genomic disorders in the general population, prevalence of autosomal CNVs, and association of these variants with educational attainment (from less than primary school through scientific degree) and prevalence of intellectual disability.
RESULTS: Of the 7877 in the Estonian cohort, we identified 56 carriers of CNVs associated with known syndromes. Their phenotypes, including cognitive and psychiatric problems, epilepsy, neuropathies, obesity, and congenital malformations are similar to those described for carriers of identical rearrangements ascertained in clinical cohorts. A genome-wide evaluation of rare autosomal CNVs (frequency, ≤0.05%; ≥250 kb) identified 831 carriers (10.5%) of the screened general population. Eleven of 216 (5.1%) carriers of a deletion of at least 250 kb (odds ratio [OR], 3.16; 95% CI, 1.51-5.98; P = 1.5e-03) and 6 of 102 (5.9%) carriers of a duplication of at least 1 Mb (OR, 3.67; 95% CI, 1.29-8.54; P = .008) had an intellectual disability compared with 114 of 6819 (1.7%) in the Estonian cohort. The mean education attainment was 3.81 (P = 1.06e-04) among 248 (≥250 kb) deletion carriers and 3.69 (P = 5.024e-05) among 115 duplication carriers (≥1 Mb). Of the deletion carriers, 33.5% did not graduate from high school (OR, 1.48; 95% CI, 1.12-1.95; P = .005) and 39.1% of duplication carriers did not graduate high school (OR, 1.89; 95% CI, 1.27-2.8; P = 1.6e-03). Evidence for an association between rare CNVs and lower educational attainment was supported by analyses of cohorts of adults from Italy and the United States and adolescents from the United Kingdom. CONCLUSIONS AND RELEVANCE: Known pathogenic CNVs in unselected, but assumed to be healthy, adult populations may be associated with unrecognized clinical sequelae. Additionally, individually rare but collectively common intermediate-size CNVs may be negatively associated with educational attainment. Replication of these findings in additional population groups is warranted given the potential implications of this observation for genomics research, clinical care, and public health.

Entities:  

Mesh:

Year:  2015        PMID: 26010633      PMCID: PMC4684269          DOI: 10.1001/jama.2015.4845

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  55 in total

Review 1.  Side effects of genome structural changes.

Authors:  Alexandre Reymond; Charlotte N Henrichsen; Louise Harewood; Giuseppe Merla
Journal:  Curr Opin Genet Dev       Date:  2007-10-24       Impact factor: 5.578

2.  Segmental copy number variation shapes tissue transcriptomes.

Authors:  Charlotte N Henrichsen; Nicolas Vinckenbosch; Sebastian Zöllner; Evelyne Chaignat; Sylvain Pradervand; Frédéric Schütz; Manuel Ruedi; Henrik Kaessmann; Alexandre Reymond
Journal:  Nat Genet       Date:  2009-03-08       Impact factor: 38.330

Review 3.  Genomic disorders: structural features of the genome can lead to DNA rearrangements and human disease traits.

Authors:  J R Lupski
Journal:  Trends Genet       Date:  1998-10       Impact factor: 11.639

4.  Recurrent reciprocal 16p11.2 rearrangements associated with global developmental delay, behavioural problems, dysmorphism, epilepsy, and abnormal head size.

Authors:  Marwan Shinawi; Pengfei Liu; Sung-Hae L Kang; Joseph Shen; John W Belmont; Daryl A Scott; Frank J Probst; William J Craigen; Brett H Graham; Amber Pursley; Gary Clark; Jennifer Lee; Monica Proud; Amber Stocco; Diana L Rodriguez; Beth A Kozel; Steven Sparagana; Elizabeth R Roeder; Susan G McGrew; Thaddeus W Kurczynski; Leslie J Allison; Stephen Amato; Sarah Savage; Ankita Patel; Pawel Stankiewicz; Arthur L Beaudet; Sau Wai Cheung; James R Lupski
Journal:  J Med Genet       Date:  2009-11-12       Impact factor: 6.318

5.  Genomewide association study using a high-density single nucleotide polymorphism array and case-control design identifies a novel essential hypertension susceptibility locus in the promoter region of endothelial NO synthase.

Authors:  Erika Salvi; Zoltán Kutalik; Nicola Glorioso; Paola Benaglio; Francesca Frau; Tatiana Kuznetsova; Hisatomi Arima; Clive Hoggart; Jean Tichet; Yury P Nikitin; Costanza Conti; Jitka Seidlerova; Valérie Tikhonoff; Katarzyna Stolarz-Skrzypek; Toby Johnson; Nabila Devos; Laura Zagato; Simonetta Guarrera; Roberta Zaninello; Andrea Calabria; Benedetta Stancanelli; Chiara Troffa; Lutgarde Thijs; Federica Rizzi; Galina Simonova; Sara Lupoli; Giuseppe Argiolas; Daniele Braga; Maria C D'Alessio; Maria F Ortu; Fulvio Ricceri; Maurizio Mercurio; Patrick Descombes; Maurizio Marconi; John Chalmers; Stephen Harrap; Jan Filipovsky; Murielle Bochud; Licia Iacoviello; Justine Ellis; Alice V Stanton; Maris Laan; Sandosh Padmanabhan; Anna F Dominiczak; Nilesh J Samani; Olle Melander; Xavier Jeunemaitre; Paolo Manunta; Amnon Shabo; Paolo Vineis; Francesco P Cappuccio; Mark J Caulfield; Giuseppe Matullo; Carlo Rivolta; Patricia B Munroe; Cristina Barlassina; Jan A Staessen; Jacques S Beckmann; Daniele Cusi
Journal:  Hypertension       Date:  2011-12-19       Impact factor: 10.190

6.  Cohort Profile: the 'children of the 90s'--the index offspring of the Avon Longitudinal Study of Parents and Children.

Authors:  Andy Boyd; Jean Golding; John Macleod; Debbie A Lawlor; Abigail Fraser; John Henderson; Lynn Molloy; Andy Ness; Susan Ring; George Davey Smith
Journal:  Int J Epidemiol       Date:  2012-04-16       Impact factor: 7.196

7.  KCTD13 is a major driver of mirrored neuroanatomical phenotypes of the 16p11.2 copy number variant.

Authors:  Christelle Golzio; Jason Willer; Michael E Talkowski; Edwin C Oh; Yu Taniguchi; Sébastien Jacquemont; Alexandre Reymond; Mei Sun; Akira Sawa; James F Gusella; Atsushi Kamiya; Jacques S Beckmann; Nicholas Katsanis
Journal:  Nature       Date:  2012-05-16       Impact factor: 49.962

8.  Genetic contributions to variation in general cognitive function: a meta-analysis of genome-wide association studies in the CHARGE consortium (N=53949).

Authors:  G Davies; N Armstrong; J C Bis; J Bressler; V Chouraki; S Giddaluru; E Hofer; C A Ibrahim-Verbaas; M Kirin; J Lahti; S J van der Lee; S Le Hellard; T Liu; R E Marioni; C Oldmeadow; I Postmus; A V Smith; J A Smith; A Thalamuthu; R Thomson; V Vitart; J Wang; L Yu; L Zgaga; W Zhao; R Boxall; S E Harris; W D Hill; D C Liewald; M Luciano; H Adams; D Ames; N Amin; P Amouyel; A A Assareh; R Au; J T Becker; A Beiser; C Berr; L Bertram; E Boerwinkle; B M Buckley; H Campbell; J Corley; P L De Jager; C Dufouil; J G Eriksson; T Espeseth; J D Faul; I Ford; R F Gottesman; M E Griswold; V Gudnason; T B Harris; G Heiss; A Hofman; E G Holliday; J Huffman; S L R Kardia; N Kochan; D S Knopman; J B Kwok; J-C Lambert; T Lee; G Li; S-C Li; M Loitfelder; O L Lopez; A J Lundervold; A Lundqvist; K A Mather; S S Mirza; L Nyberg; B A Oostra; A Palotie; G Papenberg; A Pattie; K Petrovic; O Polasek; B M Psaty; P Redmond; S Reppermund; J I Rotter; H Schmidt; M Schuur; P W Schofield; R J Scott; V M Steen; D J Stott; J C van Swieten; K D Taylor; J Trollor; S Trompet; A G Uitterlinden; G Weinstein; E Widen; B G Windham; J W Jukema; A F Wright; M J Wright; Q Yang; H Amieva; J R Attia; D A Bennett; H Brodaty; A J M de Craen; C Hayward; M A Ikram; U Lindenberger; L-G Nilsson; D J Porteous; K Räikkönen; I Reinvang; I Rudan; P S Sachdev; R Schmidt; P R Schofield; V Srikanth; J M Starr; S T Turner; D R Weir; J F Wilson; C van Duijn; L Launer; A L Fitzpatrick; S Seshadri; T H Mosley; I J Deary
Journal:  Mol Psychiatry       Date:  2015-02-03       Impact factor: 15.992

9.  Microduplications of 16p11.2 are associated with schizophrenia.

Authors:  Shane E McCarthy; Vladimir Makarov; George Kirov; Anjene M Addington; Jon McClellan; Seungtai Yoon; Diana O Perkins; Diane E Dickel; Mary Kusenda; Olga Krastoshevsky; Verena Krause; Ravinesh A Kumar; Detelina Grozeva; Dheeraj Malhotra; Tom Walsh; Elaine H Zackai; Paige Kaplan; Jaya Ganesh; Ian D Krantz; Nancy B Spinner; Patricia Roccanova; Abhishek Bhandari; Kevin Pavon; B Lakshmi; Anthony Leotta; Jude Kendall; Yoon-Ha Lee; Vladimir Vacic; Sydney Gary; Lilia M Iakoucheva; Timothy J Crow; Susan L Christian; Jeffrey A Lieberman; T Scott Stroup; Terho Lehtimäki; Kaija Puura; Chad Haldeman-Englert; Justin Pearl; Meredith Goodell; Virginia L Willour; Pamela Derosse; Jo Steele; Layla Kassem; Jessica Wolff; Nisha Chitkara; Francis J McMahon; Anil K Malhotra; James B Potash; Thomas G Schulze; Markus M Nöthen; Sven Cichon; Marcella Rietschel; Ellen Leibenluft; Vlad Kustanovich; Clara M Lajonchere; James S Sutcliffe; David Skuse; Michael Gill; Louise Gallagher; Nancy R Mendell; Nick Craddock; Michael J Owen; Michael C O'Donovan; Tamim H Shaikh; Ezra Susser; Lynn E Delisi; Patrick F Sullivan; Curtis K Deutsch; Judith Rapoport; Deborah L Levy; Mary-Claire King; Jonathan Sebat
Journal:  Nat Genet       Date:  2009-10-25       Impact factor: 38.330

10.  No effect of genome-wide copy number variation on measures of intelligence in a New Zealand birth cohort.

Authors:  Andrew T M Bagshaw; L John Horwood; Youfang Liu; David M Fergusson; Patrick F Sullivan; Martin A Kennedy
Journal:  PLoS One       Date:  2013-01-30       Impact factor: 3.240

View more
  69 in total

1.  Clinical genomics expands the morbid genome of intellectual disability and offers a high diagnostic yield.

Authors:  S Anazi; S Maddirevula; E Faqeih; H Alsedairy; F Alzahrani; H E Shamseldin; N Patel; M Hashem; N Ibrahim; F Abdulwahab; N Ewida; H S Alsaif; H Al Sharif; W Alamoudi; A Kentab; F A Bashiri; M Alnaser; A H AlWadei; M Alfadhel; W Eyaid; A Hashem; A Al Asmari; M M Saleh; A AlSaman; K A Alhasan; M Alsughayir; M Al Shammari; A Mahmoud; Z N Al-Hassnan; M Al-Husain; R Osama Khalil; N Abd El Meguid; A Masri; R Ali; T Ben-Omran; P El Fishway; A Hashish; A Ercan Sencicek; M State; A M Alazami; M A Salih; N Altassan; S T Arold; M Abouelhoda; S M Wakil; D Monies; R Shaheen; F S Alkuraya
Journal:  Mol Psychiatry       Date:  2016-07-19       Impact factor: 15.992

2.  Whole genome sequencing resource identifies 18 new candidate genes for autism spectrum disorder.

Authors:  Ryan K C Yuen; Daniele Merico; Matt Bookman; Jennifer L Howe; Bhooma Thiruvahindrapuram; Rohan V Patel; Joe Whitney; Nicole Deflaux; Jonathan Bingham; Zhuozhi Wang; Giovanna Pellecchia; Janet A Buchanan; Susan Walker; Christian R Marshall; Mohammed Uddin; Mehdi Zarrei; Eric Deneault; Lia D'Abate; Ada J S Chan; Stephanie Koyanagi; Tara Paton; Sergio L Pereira; Ny Hoang; Worrawat Engchuan; Edward J Higginbotham; Karen Ho; Sylvia Lamoureux; Weili Li; Jeffrey R MacDonald; Thomas Nalpathamkalam; Wilson W L Sung; Fiona J Tsoi; John Wei; Lizhen Xu; Anne-Marie Tasse; Emily Kirby; William Van Etten; Simon Twigger; Wendy Roberts; Irene Drmic; Sanne Jilderda; Bonnie MacKinnon Modi; Barbara Kellam; Michael Szego; Cheryl Cytrynbaum; Rosanna Weksberg; Lonnie Zwaigenbaum; Marc Woodbury-Smith; Jessica Brian; Lili Senman; Alana Iaboni; Krissy Doyle-Thomas; Ann Thompson; Christina Chrysler; Jonathan Leef; Tal Savion-Lemieux; Isabel M Smith; Xudong Liu; Rob Nicolson; Vicki Seifer; Angie Fedele; Edwin H Cook; Stephen Dager; Annette Estes; Louise Gallagher; Beth A Malow; Jeremy R Parr; Sarah J Spence; Jacob Vorstman; Brendan J Frey; James T Robinson; Lisa J Strug; Bridget A Fernandez; Mayada Elsabbagh; Melissa T Carter; Joachim Hallmayer; Bartha M Knoppers; Evdokia Anagnostou; Peter Szatmari; Robert H Ring; David Glazer; Mathew T Pletcher; Stephen W Scherer
Journal:  Nat Neurosci       Date:  2017-03-06       Impact factor: 24.884

3.  Sex chromosome aneuploidies and copy-number variants: a further explanation for neurodevelopmental prognosis variability?

Authors:  Jessica Le Gall; Mathilde Nizon; Olivier Pichon; Joris Andrieux; Séverine Audebert-Bellanger; Sabine Baron; Claire Beneteau; Frédéric Bilan; Odile Boute; Tiffany Busa; Valérie Cormier-Daire; Claude Ferec; Mélanie Fradin; Brigitte Gilbert-Dussardier; Sylvie Jaillard; Aia Jønch; Dominique Martin-Coignard; Sandra Mercier; Sébastien Moutton; Caroline Rooryck; Elise Schaefer; Marie Vincent; Damien Sanlaville; Cédric Le Caignec; Sébastien Jacquemont; Albert David; Bertrand Isidor
Journal:  Eur J Hum Genet       Date:  2017-06-14       Impact factor: 4.246

4.  2018 Victor A. McKusick Leadership Award: Molecular Mechanisms for Genomic and Chromosomal Rearrangements.

Authors:  James R Lupski
Journal:  Am J Hum Genet       Date:  2019-03-07       Impact factor: 11.025

5.  Comprehensive population-based genome sequencing provides insight into hematopoietic regulatory mechanisms.

Authors:  Michael H Guo; Satish K Nandakumar; Jacob C Ulirsch; Seyedeh M Zekavat; Jason D Buenrostro; Pradeep Natarajan; Rany M Salem; Roberto Chiarle; Mario Mitt; Mart Kals; Kalle Pärn; Krista Fischer; Lili Milani; Reedik Mägi; Priit Palta; Stacey B Gabriel; Andres Metspalu; Eric S Lander; Sekar Kathiresan; Joel N Hirschhorn; Tõnu Esko; Vijay G Sankaran
Journal:  Proc Natl Acad Sci U S A       Date:  2016-12-28       Impact factor: 11.205

6.  CHRNA7 copy number gains are enriched in adolescents with major depressive and anxiety disorders.

Authors:  Madelyn A Gillentine; Ricardo Lozoya; Jiani Yin; Christopher M Grochowski; Janson J White; Christian P Schaaf; Chadi A Calarge
Journal:  J Affect Disord       Date:  2018-07-11       Impact factor: 4.839

Review 7.  Chromosomal Microarrays: Understanding Genetics of Neurodevelopmental Disorders and Congenital Anomalies.

Authors:  Jill A Rosenfeld; Ankita Patel
Journal:  J Pediatr Genet       Date:  2016-05-30

8.  Genomic Disorders and Neurocognitive Impairment in Pediatric CKD.

Authors:  Miguel Verbitsky; Amy J Kogon; Matthew Matheson; Stephen R Hooper; Craig S Wong; Bradley A Warady; Susan L Furth; Ali G Gharavi
Journal:  J Am Soc Nephrol       Date:  2017-03-27       Impact factor: 10.121

9.  Copy number variants in the population: unselected does not mean unaffected.

Authors:  Heather C Mefford
Journal:  Epilepsy Curr       Date:  2016 Mar-Apr       Impact factor: 7.500

10.  Clinical genomics and contextualizing genome variation in the diagnostic laboratory.

Authors:  James R Lupski; Pengfei Liu; Pawel Stankiewicz; Claudia M B Carvalho; Jennifer E Posey
Journal:  Expert Rev Mol Diagn       Date:  2020-10-10       Impact factor: 5.225

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.